These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus. Snyder B; Goebel S; Koide F; Ptak R; Kalkeri R J Med Virol; 2018 Jan; 90(1):8-12. PubMed ID: 28851097 [TBL] [Abstract][Full Text] [Related]
24. Antiviral phytocompounds target envelop protein to control Zika virus. Priya S; Kumar NS; Hemalatha S Comput Biol Chem; 2018 Dec; 77():402-412. PubMed ID: 30471642 [TBL] [Abstract][Full Text] [Related]
25. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus. Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741 [TBL] [Abstract][Full Text] [Related]
26. Optimization of 1,3-disubstituted urea-based inhibitors of Zika virus infection. Khachatoorian R; Micewicz ED; Micewicz A; French SW; Ruchala P Bioorg Med Chem Lett; 2019 Oct; 29(20):126626. PubMed ID: 31477351 [TBL] [Abstract][Full Text] [Related]
27. The Race To Find Antivirals for Zika Virus. Saiz JC; Martín-Acebes MA Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348160 [TBL] [Abstract][Full Text] [Related]
28. Xanthenedione (and intermediates involved in their synthesis) inhibit Zika virus migration to the central nervous system in murine neonatal models. Poly da Silva ÍE; Lopes da Silva M; Dias RS; Santos EG; Brangioni de Paula MC; Silva de Oliveira A; Costa da Silveira Oliveira AF; Marques de Oliveira F; Canedo da Silva C; Teixeira RR; Oliveira de Paula S Microbes Infect; 2020 Oct; 22(9):489-499. PubMed ID: 32353601 [TBL] [Abstract][Full Text] [Related]
29. A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Yu Y; Deng YQ; Zou P; Wang Q; Dai Y; Yu F; Du L; Zhang NN; Tian M; Hao JN; Meng Y; Li Y; Zhou X; Fuk-Woo Chan J; Yuen KY; Qin CF; Jiang S; Lu L Nat Commun; 2017 Jul; 8():15672. PubMed ID: 28742068 [TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus. Pitts JD; Li PC; de Wispelaere M; Yang PL Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080 [TBL] [Abstract][Full Text] [Related]
31. Drugs for the Treatment of Zika Virus Infection. Bernatchez JA; Tran LT; Li J; Luan Y; Siqueira-Neto JL; Li R J Med Chem; 2020 Jan; 63(2):470-489. PubMed ID: 31549836 [TBL] [Abstract][Full Text] [Related]
32. Drug Repurposing: New Treatments for Zika Virus Infection? Cheng F; Murray JL; Rubin DH Trends Mol Med; 2016 Nov; 22(11):919-921. PubMed ID: 27692879 [TBL] [Abstract][Full Text] [Related]
33. Recent trends in ZikV research: A step away from cure. Alam A; Imam N; Farooqui A; Ali S; Malik MZ; Ishrat R Biomed Pharmacother; 2017 Jul; 91():1152-1159. PubMed ID: 28531943 [TBL] [Abstract][Full Text] [Related]
34. Editorial: Spilled Over Emerging Infectious Diseases Necessitate an Accelerated Drug Design and Discovery Program: Some Comments with Special Reference to Chemoinformatics and the Current Zika Virus Crisis. Bhattacharjee AK; Basak SC Curr Comput Aided Drug Des; 2016; 12(4):251-252. PubMed ID: 27682644 [No Abstract] [Full Text] [Related]
39. Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections. Chen WC; Simanjuntak Y; Chu LW; Ping YH; Lee YL; Lin YL; Li WS J Med Chem; 2020 Feb; 63(3):1313-1327. PubMed ID: 31972088 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Adcock RS; Chu YK; Golden JE; Chung DH Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]